NewAmsterdam Pharma Company N.V. Stock Price
Last Done:
SGD 9.39
+0.12 (+1.31%)
• Login required for live price
Open: --
High: --
Low: --
Prev Close: --
Login to unlock live stock price, change %, and intraday data.
Login to View
Market: NASD |
Currency: USD
Address: Gooimeer 2-35
NewAmsterdam Pharma Company N.V., a late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with metabolic disease. It is developing obicetrapib, an oral low-dose cholesteryl ester transfer protein (CETP) inhibitor, that is in various clinical trials as a monotherapy and a combination therapy with ezetimibe for lowering LDL-C for cardiovascular diseases. The company also develops Obicetrapib which is in Phase 2a clinical trial for Alzheimer's disease. NewAmsterdam Pharma Company N.V. is headquartered in Naarden, the Netherlands.
📈 NewAmsterdam Pharma Company N.V. Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
$50.29
-
Upside/Downside from Analyst Target:
50.92%
-
Broker Call:
30
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
25-50%
-
Net Income Growth Range (1Y):
10-25%
-
Revenue Growth Range (1Y):
<0%
-
Upcoming Earnings Date:
2026-05-07
-
EPS Estimate:
-0.42
💰 Dividend History
No dividend history available.
📅 Earnings & EPS History for NewAmsterdam Pharma Company N.V.
| Date | Reported EPS |
|---|
| 2026-05-07 (estimated upcoming) | - |
| 2026-02-18 | -0.53 |
| 2025-11-05 | -0.53 |
| 2025-08-06 | -0.13 |
| 2025-05-08 | -0.3 |
| 2025-02-26 | -0.9 |
| 2024-11-06 | -0.16 |
| 2024-08-07 | -0.38 |
| 2024-05-08 | -0.99 |
📰 Latest Corporate News
No latest corporate news found for this symbol.
📰 Related News & Research
🔍 View more Reports
